Better reporting of randomised controlled trials: the CONSORT statement. BMJ
Clinical Trials: A Practical Approach. Chichester, Wiley, 1983..
Statistical Issues in Drug Development. Chichester, Wiley, 1997..
ORACLE Collaborative Group. Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. ORACLE Collaborative Group. Lancet
2001;357:989–94., , ;
ORACLE Collaborative Group. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. ORACLE Collaborative Group. Lancet
2001;357:979–88., , ;
Assessing new interventions in women’s health. Best Pract Res Clin Obstet Gynaecol
Problems in publication of clinical trial methodology. Clin Pharmacol Ther
Multicentre randomised controlled trials in obstetrics and gynaecology: an analysis of trends over three decades. BJOG
2009;116:1130–4., , .
Methodology and analytic techniques used in clinical research: associations with journal impact factor. Obstet Gynecol
2009;114(4):877–84., , .
National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. What we have learned about conducting randomized controlled trials in the NICHD MFMU network. Semin Perinatol
Planned caesarean section versus planned vaginal birth for breech presentation at term: a randomised multicentre trial. Term Breech Trial Collaborative Group. Lancet
2000;356:1375–83., , , et al.
Vitamins in Pre-eclampsia (VIP) Trial Consortium. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet
2006;367:1145–54., , , , ;
Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis. Lancet
2009;373(9680):2034–40., , , et al.
A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervico-vaginal fetal fibronectin: the PREMET Study. BJOG
2006;113:65–74., , , et al.
Randomised double blind placebo controlled trial of rofecoxib (a cox-2 specific prostaglandin inhibitor) for the prevention of preterm delivery in women at high risk. BJOG
2005;112(6):725–30., , , ,
Comparative Obstetric Mobile Epidural Trial (COMET) Study Group UK. Effect of low-dose mobile versus traditional epidural techniques on mode of delivery: a randomised controlled trial. Lancet 2001;358:19–23.
Market failure and the poverty of new drugs in maternal health. PLoS Med
National Institute of Child Health and Human Development Maternal-Fetal Medicine units Network. Long-term outcomes after repeat doses of antenatal cortiosteriods. N Engl J Med
, , et al.
National Institute of Child Health and Human Development Maternal-Fetal Medicine units Network. Prevention of recurrent preterm delivery by 17-alpha hydroxyprogestrone caproate. N Engl J Med
2003;348:2379–85., , , et al.
National Institute of Child Health and Human Development Maternal-Fetal Medicine units Network. Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery. N Engl J Med
2004;351:2581–90., , , et al.
The Control of Hypertension in Pregnancy Study pilot trial. BJOG
2007;114:13–20., , , et al.
Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial. Lancet
2008 ;372:2143–51., , , et al.
Does internal tocodynamometry improve the outcome of labour? A randomised controlled trial comparing monitoring of contractions with an intrauterine pressure catheter to an external tocotransducer during induced or augmented labor. N Engl J Med
2010;362:306–13., , , et al.
Induction of labour versus expectant monitoring in women with pregnancy induced hypertension or mild preeclampsia at term: the HYPITAT trial. Lancet
2009;374:979–88., , , et al.
for the Global obstetrics Network. Global adjustment, coordination and collaboration in perinatal research: The Global obstetrics Network (GONet initiative. Aa J Perinatol
2012: in press., ,